CUV 0.69% $30.30 clinuvel pharmaceuticals limited

phase 2 results due very soon

  1. 3,567 Posts.
    Epitan will be finished their clinical trials very shortly and we already know the product is working very well. Surely the current market cap is cheap for such a product. Any thoughts?

    Also notice more analysts starting to look at biotechs seriously again. Reports for EPT suggest a price 2-3 times higher than current prices and thats before phase II is released.

    Is this stock a buy???
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.497B
Open High Low Value Volume
$30.50 $30.80 $29.85 $2.232M 73.72K

Buyers (Bids)

No. Vol. Price($)
1 83 $30.30

Sellers (Offers)

Price($) Vol. No.
$30.33 305 1
View Market Depth
Last trade - 16.10pm 16/04/2021 (20 minute delay) ?
-0.210 ( 0.53 %)
Open High Low Volume
$30.20 $30.57 $29.90 7502
Last updated 15.59pm 16/04/2021 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.